Board of Directors

Dr. Kamal Mekhael – Chairman of the Board

Dr. Mekhael is a Financial Planner and Chartered Broker. He is president of his own financial services firm. Prior to his business career, Dr. Mekhael obtained his Ph.D. in pharmacy from the Bio-pharmaceutical Centre of Geneva University in Switzerland followed by Post-Doctoral work and teaching experience at both McGill University and Concordia University . Dr. Mekhael possesses extensive experience in the bio-pharmaceutical industry as well as the financial services domain.

Dr. Brian Morris – President and CEO

Dr. Morris graduated from McGill with a B.Sc. in 1970 and a Doctorat en Médecine from Université de Reims, France, in 1977. Following an internship at Memorial University, Newfoundland, he did a residency in urology at McGill. He was a lecturer at McGill and does clinical teaching at St. Mary’s Hospital. He was a consultant urologist at the Queen Elizabeth Hospital until its closing and he currently operates at St. Mary’s Hospital. Dr. Morris has also an office practice at the Westmount Medical Building. He has participated in numerous research projects and is a member of the following associations: CMA, QMA, CUA, QUA, EUA, CMPA, FMSQ, CUOG, and SIU. He is Fellow of the Royal College of Physicians and Surgeons of Canada. He is consultant at the Commission de la Santé et de la Sécurité du Travail (CSST) and at the law firm McCarthy Tétreault.

Roberto Bellini – Vice President of the Board

Mr. Bellini currently serves as the President and CEO of BELLUS Health Inc. – a development-focused health company concentrating on the development of products that provide innovative health solutions and address critical unmet medical needs. Prior to 2010, Mr. Bellini oversaw the licensing and partnering activities of BELLUS Health Inc. Mr. Bellini’s experience includes responsibility for the investment and operational activities of Picchio Pharma Inc., a joint venture healthcare investment firm owned by FMRC Family Trust and Power Technology Investment Corporation. He was also an assistant to the CEO at Adaltis Inc, an in-vitro diagnostics company. He is a sitting member of the Board of Directors of Thallion Pharmaceuticals Inc. and BELLUS Health Inc.
Mr. Bellini holds a Bachelor of Science in Biochemistry from McGill University.

Mr. Alain Gourd – Secretary of the Board

Lawyer and Master of Arts (Philosophy), Mr. Gourd has distinguished himself through his initiative in the tele-communication industry. He has been Chairman of the Board and CEO for Bell ExpressVu, and Vice-President of corporate affairs for Bell Globemedia. He has also served in the Federal Government of Canada as the Deputy Minister of Communication and Associate Secretary to the Cabinet. Besides his passion for communication, Mr. Gourd has always put great emphasis on higher education. The Université du Québec en Outaouais has granted him a Doctorate Honoris Causa. Amongst his volunteer activities, Mr. Gourd is immediate past Chair of the Canadian Colorectal Cancer Association. He was also Chair of the 2008 Canadian Health Care Forum.

Dr. Shatha Al-Musawi – Member of the Board

Dr Al-Musawi graduated in general medicine from the 2nd Moscow State Pirogov Medical Institute. She then specialised in rheumatology at the Institute of Rheumatology Academy of Medical Sciences of the USSR, where she received her master’s degree. Dr Al-Musawi also holds a doctorate in medicine, awarded by the Council of the Institute of Rheumatology, USSR Academy of Medical Sciences.

Designed by Mosca Media